Treatment of Tinea Cruris
Tinea cruris should be treated with topical antifungal agents as first-line therapy, with oral antifungals reserved for extensive disease or when topical treatments have failed. 1
First-Line Treatment
Topical Antifungals
Azole antifungals:
Allylamine antifungals:
The fungicidal allylamines (terbinafine) and butenafine allow for shorter treatment duration compared to fungistatic azoles, but may be more costly 4
Second-Line Treatment (Extensive Disease or Treatment Failure)
Oral Antifungals
Terbinafine: 250 mg once daily for 1 week 5
- Highly effective with complete clinical and mycological clearance after 1 week
Itraconazole: 100 mg daily for 2 weeks or 200 mg daily for 1 week 1
- Superior to oral griseofulvin in treating tinea cruris
Fluconazole: 150 mg once weekly for 2-4 weeks 6
- Effective for multiple or extensive infection sites
Treatment Duration and Follow-up
- Continue treatment for at least one week after clinical clearing of infection 3
- Clinical improvement is typically seen soon after treatment begins, but complete the full course to prevent recurrence 2
Additional Measures for Prevention and Management
- Complete drying of the crural folds after bathing
- Use separate clean towels for drying the groin and other body parts
- Cover active foot lesions with socks before wearing undershorts to prevent spread from tinea pedis
- Wear loose-fitting clothing and change underwear daily 1
Important Clinical Considerations
- Confirm diagnosis with potassium hydroxide (KOH) preparation before initiating treatment when possible
- For inflamed lesions, short-term use of combination antifungal/steroid agents may be considered, but use with caution due to potential for atrophy 3
- If no clinical improvement is seen after the treatment period, reconsider the diagnosis 2
Treatment Algorithm
- Confirm diagnosis (clinical + KOH if available)
- Start with topical antifungal (terbinafine for shorter course or azole if cost is a concern)
- If extensive disease or treatment failure, proceed to oral therapy
- Continue treatment for at least one week after clinical clearing
- Implement preventive measures to avoid recurrence